As part of NSF’s ongoing efforts to innovate and migrate proposal preparation and submission capabilities from FastLane to Research.gov (see Important Notice No. 147), the Directorate for Biological Sciences (BIO) has announced that proposal submissions for our “no-deadline” programs will migrate to Research.gov beginning with revised solicitations to be released in the near future. This change was announced in a Dear Colleague Letter (NSF 20-129) released today and is the first phase of a migration of all NSF solicitations to Research.gov.
Specifically, the following programs will have new solicitations published in the coming weeks at which point investigators should begin submitting proposals through Research.gov. There will be a grace period of 90-days from the date on which the new solicitations are published during which proposals can still be submitted through FastLane. After the 90-day period, the new solicitations will no longer be available in FastLane and any new proposals must be submitted through Research.Gov (or Grants.Gov).
The programs whose solicitations will migrate from FastLane to Research.gov are:
Research.gov improves the user experience while also reducing administrative burden. The system is also flexible enough to meet both users’ changing needs and emerging government requirements. A significant fraction of proposals is already being submitted through Research.gov and investigators report it to be intuitive to use. We do not anticipate that the change to Research.gov will have significant impacts on the submission process. This migration will not affect the merit review process in any way.
The virtual office hours will occur on Monday, October 19 at 11 a.m. EDT; Tuesday October 20 at 10 a.m. EDT; Wednesday, October 21 at 1 p.m. EDT; and Thursday, October 22 at 3 p.m. EDT. Members of the community can register for these sessions via NSF.gov.
Finally, if you have any immediate questions please reach out to BIOnodeadline@nsf.gov, which is monitored by Program Officers from across BIO.
The Directorate for Biological Sciences (BIO), and NSF more broadly, understands the impact that COVID-19 and the responses thereto are having on the research community. We have heard from numerous community members and societies about lab closures, stresses associated with transitions to virtual classrooms and determining new methods of supporting students, and the loss of administration time and resources to COVID-related campus-wide planning. We know that these are affecting, and will continue to affect, the research enterprise by straining resources, ending or delaying planned research and/or impeding training and education, and we are committed to being responsive to the community in these difficult times. With this post, I would like to share with you information about NSF’s current operations and provide guidance to current awardees. But, most importantly, I want to emphasize that personal safety is the highest priority and I hope that you and your loved ones stay safe and healthy in this difficult time.
NSF current operations: BIO program staff are on duty and available to the community, albeit virtually, and we welcome your proposal submissions at any point in the coming weeks and months. We are continuing to review proposals and make awards in a timely fashion and have implemented fully virtual panels to complete this process. Based on feedback from BIO panelists during my own video conversations with them, the high quality of the NSF merit review process is being sustained. Moreover, because NSF is uniquely prepared to respond quickly to address scientific unknowns concerning this coronavirus, Agency staff are working hard to review the literally hundreds of requests for RAPID funding being submitted each week.
As a reminder, the core programs throughout BIO do not have submission deadlines and we have extended the few special programs that do have deadlines. An agency-wide list of solicitations and Dear Colleague Letters for which deadlines have been extended can be found here.
Current awardees: On March 23, NSF released guidance for all awardees on how to mitigate the impacts these challenging times are having and will have. NSF Director France Córdova also released an accompanying letter to the research community noting that “we are committed to providing the greatest available flexibilities to support your health and safety as well as your work.”
For current awards, grantees and program officers also have flexibility to provide no-cost extensions. NSF gives all awardee organizations the authority to extend an award for one year of no-cost extension (NCE) without needing to seek NSF approval. That first-year extension is called a Grantee-Approved extension and should be utilized prior to requesting an NSF-Approved extension. Your organization’s grants office simply needs to inform NSF, two weeks prior to the end of the award, that they intend to use a Grantee-Approved NCE by sending a notification to NSF via Research.gov. If additional time beyond the first year of extension is required, a formal request for an NSF-Approved NCE can be submitted by the organization’s grants officer via Research.gov prior to the end date of the grant. BIO program officers will accommodate such requests for a second year of NCE associated with delays due to COVID-19.
Finally, I and all the Directorate staff are interested in hearing how, in addition to those ways outlined above, BIO and NSF can mitigate the longer-term harm of COVID-19 on U.S. research and training. We will be holding a series of four BIO-wide virtual office hours next week where you can share concerns, ask questions, or offer your suggestions on how we can do more to address this national emergency. Sessions will be held at 4 pm Monday, March 30; 3 pm Tuesday, March 31; 2 pm Wednesday, April 1; and 1 pm Thursday, April 2; all times are EDT. Please feel free to attend the session that best fits your schedule; representatives from across BIO will be in attendance during each session.
For more information on NSF’s activities and response to COVID-19, please visit our coronavirus information page; this site is updated regularly.
Joanne S. Tornow, Ph.D.
Assistant Director for Biological Sciences
Please join the Directorate for Biological Sciences (BIO) for the 2020 Distinguished Lecture Series.
BIO’s Distinguished Lecture Series brings eminent researchers to NSF Headquarters in Alexandria, Virginia to speak to BIO scientists, other scientists in the agency, staff members, and a broader Washington-area audience about their research.
Below is more information about the 2020 Distinguished Lecture Series Speakers. Refer to BIO’s homepage for updated information as the lecture dates get closer.
If you wish to attend in person at NSF Headquarters (2415 Eisenhower Ave, Alexandria, VA 22314), please contact Nick Hunt (firstname.lastname@example.org). Advance sign-up requests are required, and guidelines for visiting NSF are at https://www.nsf.gov/about/visit/
I hope you will be able to attend what are sure to be stimulating and thought-provoking lectures.
Joanne Tornow, PhD
Assistant Director for Biological Sciences
I am deeply saddened to inform you of the passing of Dr. Mary Clutter.
Dr. Clutter served as the Assistant Director (AD) for the Directorate for Biological Sciences (BIO) from 1992 to 2005, during which time she served two stints as acting Deputy Director for NSF. Prior to that, she served as Division Director for Cellular Biosciences in what was previously the Directorate for Biology, Behavioral, and Social Sciences (BBS), as Science Advisor in the Office of the Director from 1985 to 1987, and as a Program Director starting in the 1970s. She passed away on Sunday, December 8, 2019.
Dr. Clutter was a native of Pennsylvania and attended Allegheny College, where she obtained an undergraduate degree in biology. She later earned her masters and doctorate degrees from the University of Pittsburgh. She joined NSF as a rotator from Yale University and subsequently was appointed permanently.
Dr. Clutter was always about science first. Her prescient view of 21st Century Biology predicted it to be integrative from the molecule to the environment, interdisciplinary across all disciplines, driven by a revolution in genomics and computational biology. She championed plant biology and genomics, advocated for the creation of the National Ecological Observatory Network (NEON), and fostered innovative funding mechanisms within BIO (e.g., Research Coordination Networks and Graduate Research Traineeships) that were subsequently embraced agency-wide. Furthermore, her commitment to advancing women in academe, in science, and at the NSF was a major hallmark of her time as AD for BIO. Most notable was her policy memo that prohibited BIO funding of workshops and conferences that did not include women among the presenters, a courageous stance that was noted at the time by the Washington Post. Dr. Clutter is also credited with the second largest reorganization within NSF in 1992 that resulted in the creation of the Directorates for Biological Sciences and Social, Behavior and Economic Sciences.
Dr. Mary Clutter leaves behind a vibrant legacy that will live on in the memories of her NSF colleagues. We are forever grateful for her service, dedication, and visionary leadership.
Joanne Tornow, PhD
Assistant Director for Biological Sciences
BIO is excited to announce to the biological sciences community two new funding opportunities under the Understanding the Rules of Life (URoL) Big Idea: 1) Epigenetics and 2) Microbiome Theory and Mechanisms (MTM). The URoL Big Idea seeks to create a new paradigm at the convergence of science, engineering, and technology that will elucidate theoretical frameworks (rules) to enable prediction of the diversity of evolutionary solutions that biological systems use to support life processes seen across the planet. The National Science Foundation has recently invested $36 million in the first projects under the URoL portfolio from two separate solicitations and across more than thirty institutions.
The Epigenetics and MTM opportunities represent a collaboration across Directorates and Offices within the National Science Foundation. Specifically, Epigenetics intends to enable innovative research and promote multidisciplinary education and workforce training in the broad area of epigenetics, while MTM aims to understand and establish theory and mechanisms that govern the structure and function of microbiomes.
Integrative perspectives and research approaches from more than one research discipline are welcomed, as this is a cross-Directorate effort. The interdisciplinary scope of both programs aims to provide unique training and outreach opportunities to train the next generation of scientists in a diversity of scientific approaches and to engage society more generally.
Both programs offer two submission tracks:
Track 1 – for projects with a total budget of up to $500,000 and an award duration of up to 3 years, and
Track 2 – for projects with a total budget of up to $3,000,000 and award duration of up to 5 years.
BIO is excited to be back to work following the long lapse in appropriations. We thank the biological sciences community for its patience and its support of students, postdocs, faculty, technical and administrative support staff and researchers during this challenging time.
Fortunately, because BIO core programs have a no-deadline submission process and relevant systems remained online during the shutdown, BIO has experienced few disruptions to our division programs. However, this also means that we have a backlog of submitted proposals and missed panels. As we get our systems up and running again, we are establishing processes that will enable us to focus on high-priority areas, particularly in light of the three-week continuing resolution. Our staff is working hard to reschedule cancelled merit review panels and process awards, and is prioritizing in particular the review and funding of postdoctoral fellowships and REU site awards. As we work to expedite the return to normal operations, I call upon the volunteerism of the reviewer community and ask for your flexibility in participating in rescheduled and virtual panels.
In addition to addressing the backlog of activities from the lapse, BIO remains committed to delivering on ongoing competitions, including the Understanding Rules of Life competitions. Please note that deadline dates for BIO special solicitations and DCLs remain unchanged.
A special note to our colleagues in the ecological sciences community about the changes that took place at the National Ecological Observatory Network (NEON) during the lapse in appropriations: Now that NSF has resumed operations, we are re-engaging with all key stakeholders in the project. I remain fully committed to ensuring that NEON realizes its scientific promise as it transitions to full operations. I wish to express my gratitude to all those who have worked together to bring NEON construction to the finish line, including Battelle staff and NEON’s Science, Technology and Education Advisory Committee (STEAC), and thank the STEAC for their thoughtful engagement and continued commitment to NEON.
I once again thank you for your patience in this challenging time and ask for your continued support as we work to get back on track as soon as possible.
Joanne Tornow, PhD
Assistant Director for Biological Sciences
In August, the BIO directorate released new solicitations to its proposal submission process to eliminate deadlines and limit the number of proposals that could be submitted to a given division annually by a PI or co-PI. As BIO was receiving far more worthy proposals than it has money to support, this submission cap was established with a view to ensuring that BIO’s merit review process would not be overwhelmed with the move to no deadlines.
In the ensuing three months, the community expressed serious concern that this new policy would hinder collaboration as well as limit funding prospects for new investigators. BIO places a high value on collaboration and on fostering careers of new investigators; thus, we held internal discussions to consider ways to address these concerns. In addition, relatively few proposals have been submitted to BIO since the release of the solicitations.
Having listened to community concern and tracked the current low rate of submission, and following extensive internal consultation, BIO is lifting all PI or co-PI restrictions on proposal submission for FY 2019, effective immediately.
BIO recognizes that it is important to track the effects of the no-deadline policy on proposal submission patterns, to ensure that a high-quality review process is sustained. Therefore, we are seeking approval from the Biological Sciences Advisory Committee to establish a subcommittee to assist in developing the evidence base for any future policy changes that may be needed.
Solicitations for proposals will be amended and released over the next few weeks to reflect these changes.
Joanne Tornow, PhD
Acting Assistant Director for the Biological Sciences
This is an exciting time for the biological sciences. The way we do science is rapidly changing; it is increasingly collaborative, interdisciplinary, and enhanced by new capability to collect and analyze more complex data than ever before. We at the National Science Foundation Directorate for Biological Sciences (BIO) are committed to creating funding opportunities that foster collaboration and innovative research to advance biological knowledge. As part of this effort, we have recently made changes to enable us to respond to this changing research environment and continue to meet the needs of our community – early career and senior scientists alike – as it progresses into the future.
We have just released a set of solicitations designed to support the biological sciences community broadly and to take advantage of emerging research opportunities. In addition to retaining all core and special funding programs, we have added a new funding opportunity: a Rules of Life track, which provides new mechanisms for review and funding of ambitious, integrative research projects addressing questions across scales that would not ordinarily fit well within a single BIO division. With these solicitations, we have also completed our initial transition to a BIO-wide no deadline submission process. By accepting proposals at any time, BIO aims to encourage submission of creative, well-developed, interdisciplinary projects by providing investigators with greater flexibility to prepare their proposals.
Given that BIO already receives many more excellent, funding-worthy proposals than we have money to support, more submission opportunities do not equate to more awards. Thus, with a shift to no deadlines, it was clear there needed to be some restrictions to limit submission and resubmission of similar proposals within a given year. After extensive consideration, conversations with key community stakeholders, and analysis of past submission patterns, we determined the most balanced way to do this was to limit annual submissions as PI or co-PI. Each year, researchers may submit one proposal each to MCB, IOS and DEB core programs, and two proposals to DBI infrastructure programs. In addition, researchers may submit one proposal to the Rules of Life track each year. Further, to ensure that this cap does not harm collaborative projects, we have removed previous restrictions on submissions as subaward PIs. We sought an objective way to limit proposal submissions to carefully considered, unique research ideas, while removing barriers to collaboration by allowing unlimited involvement on proposals with potential to receive budgets.
We recognize concerns have been expressed about potential negative impacts of this shift, and I can assure the community that we have extensively considered these same issues. We have paid particular attention to the possible impacts on early career researchers. We are confident these caps will not harm their opportunities to receive research funding; in addition to the funding opportunities open to all researchers within BIO, early career researchers will remain eligible to apply for CAREER awards. Nurturing the next generation of biologists is a priority for BIO program staff, and we will continue to monitor progress closely. I encourage the community to read the FAQs and blogs posted by each division on the new submission cap and shift to no deadlines for answers to common questions and more details on the opportunities available within BIO. As we go through this first year under the new submission system, BIO will track these and other areas of concern and will evolve as necessary.
Collectively, these new solicitations offer many opportunities for innovative, challenging and potentially transformative science. I am eager to see how our new solicitations will move forward BIO’s mission to enable discoveries for understanding life and advance the frontiers of biological knowledge.
Joanne Tornow, PhD
Acting Assistant Director for the Biological Sciences
BIO recently welcomed a new Acting Assistant Director, Dr. Joanne Tornow. Though she is coming to BIO after six years in NSF’s Directorate for Social, Behavioral and Economic Sciences and the Office of Information and Resource Management, Dr. Tornow is no stranger BIO, having spent more than a decade in a variety of roles across the Directorate. We sat down with Dr. Tornow to get to know her a little better and welcome her back to her first home at NSF.
When did your interest in the sciences first begin?
I trace back my falling in love with biology and genetics to my 9th grade biology class. It all just made perfect sense and I loved it, so from then on, I was a biology person. At the time that I was in college, molecular biology did not really exist as a discipline, but microbial biology and microbial and molecular genetics was just starting, so I concentrated on what was then a very emerging area of microbial genetics. As I progressed, there was really very little debate in my own mind about what I was interested in. I love biology and knew I wanted to pursue it as a career.
Can you tell us a little bit about your journey from a career as a traditional, academic researcher to science administrator?
I did the traditional academic path – graduate school, postdoc, faculty position – and then there was an opportunity during my sabbatical to do something completely different that I was really interested in.
At the time, Dolly had just been cloned the year before and we were in the middle of the Human Genome Project. I was teaching genetics to undergraduates and molecular genetics graduate students, and these events were raising all of these questions about the intersection of science and policy, genetic privacy, cloning – it was really a fascinating time. So when I stumbled on the AAAS policy fellowship, I thought it would be a great opportunity to go and see how the policy side intersected with the science and then bring that back to the classroom.
I spent a year working on the Senate Veterans’ Affairs committee, getting experience working on the Hill and understanding how that process worked – how the federal budget is generated and how it drives policy. Then an opportunity came up to go to OSTP [the White House Office of Science and Technology Policy] for a year, and there I was able to work on things that were a little bit more relevant to my science.
What was your favorite part of working on the policy side of things?
Just a month or two after I started my fellowship in OSTP, the first papers on isolating human embryonic stem cells came out. Every month or so, something else was getting cloned. It created some really great policy questions, and so it was a wonderful time for me to be at OSTP – that was a fabulous year.
How did you ending up coming to NSF?
At the end of that year, I was getting ready to go back to my institution. I had been in contact with NSF because I knew that when I had initially planned to come to DC on my sabbatical that NSF had been an option. A position was available as a rotator and they reached out to me. By that time, after two years in DC I had sort of made the switch in my mind from doing the academic life to thinking about science in the bigger context, and it was really appealing to me both personally and professionally to stay in this area, so I took the position.
You and BIO have a long history together! When were you last here, and what projects were you involved with?
Starting in the Fall of 1999, I was program director for gene expression in the division of Molecular and Cellular Biosciences (MCB). The portfolio for gene expression was much broader than understanding the control of transcription, which was my area of expertise. I was a program director in MCB for about six and a half years before leaving for a little bit to do a detail in the Directorate for Education and Human Resources (EHR) front office.
After that, I came back to be senior advisor in the BIO front office, but as it turned out, I went up to the Director’s office for about 8 months on a detail to work on a particular project for the Deputy Director, and so spent very little time in the front office. After that, I returned to BIO and was the Acting Division Director for MCB for two years.
By that time [former BIO AD] Jim Collins was finishing up his tenure and left, and I moved in to be the acting Executive Officer [equivalent to the current Deputy Assistant Director]. When a new AD was found two years later, there were a variety of vacancies in the Deputy AD spots, so I applied for those and that’s when I moved to the Directorate for Social, Behavior and Economic Sciences (SBE) as Deputy AD.
Each of these jobs – that whole path, including my details in EHR and in the OD, and my time in OIRM – all gave me different perspectives and really helped me when I came back to be an Acting Division Director and now Acting Assistant Director in BIO. Having spent the time at OSTP, on the Hill, in the OD – all of those experiences helped me be more effective here at NSF.
What are you most looking forward to for your time as Acting Assistant Director for BIO?
There are a couple of things that I’m really looking forward to. One is that it’s been six years since I’ve been in BIO and I’m just really loving getting back in touch with BIO and catching up on all that’s happened – all the ways that the science and the programs in BIO have advanced. So that’s probably the best part about this – I’m really just getting back to my first love.
On January 10, 2018, Dr. Jim Olds’ term as Assistant Director for Biological Sciences came to an end. Since taking up the post in September 2014, Dr. Olds has led BIO through many big changes, including the conception of the Rules of Life Big Idea and implementation of a no-deadline submission mechanism for receiving and reviewing proposals. All of us at BIO would like to thank Dr. Olds for his excellent leadership over the past three and a half years, and wish him the best as he returns to George Mason University.
Dr. Joanne Tornow, Head of the Office of Information and Resource Management (OIRM) and former BIO Acting Deputy Assistant Director, will be taking up the mantle as Acting Assistant Director for BIO while the search for Dr. Olds’ successor is underway. Stay tuned to learn more about Dr. Tornow and the exciting things she has planned for the directorate in the coming months!